Murli Krishna Pharma Pvt Ltd is a dynamic and innovative organization specializing in Novel Drug Delivery Systems (NDDS). We offer a comprehensive range of effective solutions aimed at optimizing the delivery of Oral Solid Dosage (OSD) forms. Our state-of-the-art manufacturing facility is equipped with modern machinery and facilities, adhering to 21 CFR Part 11 compliance.
Our expertise encompasses the production of pre-finished formulations of Oral Solid Dosage forms, including Pellets, Granules, and MUPS, utilizing Aqueous-Based technology. Additionally, we specialize in Nano-Particles, Transdermal lotion, Oncology OSD, Injections, General Injectables, and Ophthalmics. Our commitment to quality is reflected in our global presence, with products registered in various parts of the world and Drug Master Files in CTD 3.2.P format, along with Dossiers for Finished Dosage Forms.
Accreditations & Certifications:
World Health Organization – GMP Certified
European Union – GMP Certified
Jordanian FDA – GMP Certified
R&D facility – Approved by DSIRT, Govt. of India for Innovative research.
Global Presence:
Currently, we operate in 78 countries, serving over 200 customers globally. While commercial supplies are active in most of these countries, projects are in the pre-commercial phase in some. Notable clients include Mylan Laboratories Limited, Sanofi Ltd, Pfizer Ltd, Novartis, and Sandoz.
